EA
ALHC icon

Evolution Advisers’s Alignment Healthcare ALHC Stock Holding History

Evolution Advisers’s Portfolio ALHC Stock Details ALHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+7
New +$134 ﹤0.01% 239

Other funds holding ALHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Evolution Advisers's ALHC Position: Q2 2026 in Review

Evolution Advisers opened a new position in Alignment Healthcare (ALHC) in Q2 2026: 7 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #239 among its holdings.

323 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Evolution Advisers held 7 shares of Alignment Healthcare worth $0 as of Q2 2026.
  • Alignment Healthcare was a new Evolution Advisers position in Q2 2026.
  • Alignment Healthcare made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #239 holding.
  • 323 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.